Caribou Biosciences (CRBU) Stock Forecast & Price Target

$2.49

+0.05 (+2.05%)

(As of 07/26/2024 ET)

Caribou Biosciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 4 Analyst Ratings

Based on 4 Wall Street analysts who have issued ratings for Caribou Biosciences in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 4 analysts, 1 has given a hold rating, and 3 have given a buy rating for CRBU.

Consensus Price Target

$15.25
512.45% Upside

High Forecast	$30.00
Average Forecast	$15.25
Low Forecast	$3.00

According to the 4 analysts' twelve-month price targets for Caribou Biosciences, the average price target is $15.25. The highest price target for CRBU is $30.00, while the lowest price target for CRBU is $3.00. The average price target represents a forecasted upside of 512.45% from the current price of $2.49.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	5 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$15.25	$15.25	$22.50	$26.50
Forecasted Upside	512.45% Upside	346.84% Upside	310.48% Upside	296.44% Upside

Get Caribou Biosciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter.

Ad Stansberry Research

Get out of cash before the Fed's next meeting

"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."

Click here now to watch this exclusive interview

CRBU Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRBU Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Caribou Biosciences Stock vs. The Competition

Type	Caribou Biosciences	Medical Companies	S&P 500
Consensus Rating Score	2.75	2.72	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	512.45% Upside	2,864.75% Upside	9.14% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/17/2024	HC Wainwright 3 of 5 stars		Reiterated Rating	Buy ➝ Buy	$9.00 ➝ $9.00	+229.67%
6/3/2024	Evercore ISI 2 of 5 stars	L. Bayko Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Inline	$13.00 ➝ $3.00	+4.17%
5/16/2024	Truist Financial 1 of 5 stars		Reiterated Rating	Buy ➝ Buy	$19.00 ➝ $19.00	+426.31%
11/8/2023	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Bienkowski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral
9/5/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$37.00 ➝ $30.00	+410.20%
3/17/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$27.00 ➝ $25.00	+404.03%
3/10/2023	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform	$19.00	+257.81%
3/10/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$36.00 ➝ $32.00	+480.76%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:50 AM ET.

CRBU Forecast - Frequently Asked Questions

What is Caribou Biosciences' forecast for 2024?: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Caribou Biosciences is $15.25, with a high forecast of $30.00 and a low forecast of $3.00.
Should I buy or sell Caribou Biosciences stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Caribou Biosciences in the last year. There is currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CRBU shares.
Does Caribou Biosciences's stock price have much upside?: According to analysts, Caribou Biosciences's stock has a predicted upside of 325.98% based on their 12-month stock forecasts.
Has Caribou Biosciences been downgraded by Wall Street analysts recently?: Over the previous 90 days, Caribou Biosciences's stock had 1 downgrade by analysts.
What analysts cover Caribou Biosciences?: Caribou Biosciences has been rated by research analysts at Evercore ISI, HC Wainwright, and Truist Financial in the past 90 days.
Do Wall Street analysts like Caribou Biosciences more than its competitors?: Analysts like Caribou Biosciences more than other "medical" companies. The consensus rating score for Caribou Biosciences is 2.75 while the average consensus rating score for "medical" companies is 2.72. Learn more on how CRBU compares to other companies.